These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7371038)

  • 21. Dietary fish oil does not prevent doxorubicin-induced cardiomyopathy in rats.
    Matsui H; Morishima I; Hayashi K; Kamiya H; Saburi Y; Okumura K
    Can J Cardiol; 2002 Mar; 18(3):279-86. PubMed ID: 11907617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interval-force relationship: a technique for evaluating the cardiac toxicity of anthracycline analogs.
    Breed JG; Zimmerman AN; Meyler FL; Pinedo HM
    Cancer Treat Rep; 1979 May; 63(5):869-73. PubMed ID: 455328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transgenic mice overexpressing metallothionein are not resistant to adriamycin cardiotoxicity.
    DiSilvestro RA; Liu J; Klaassen CD
    Res Commun Mol Pathol Pharmacol; 1996 Aug; 93(2):163-70. PubMed ID: 8884987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells.
    Abou El Hassan MA; Heijn M; Rabelink MJ; van der Vijgh WJ; Bast A; Hoeben RC
    Cancer Gene Ther; 2003 Apr; 10(4):270-7. PubMed ID: 12679799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid lowering: an important factor in preventing adriamycin-induced heart failure.
    Iliskovic N; Singal PK
    Am J Pathol; 1997 Feb; 150(2):727-34. PubMed ID: 9033285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
    Saad SY; Najjar TA; Alashari M
    J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrolyte and morphologic alterations of myocardium in adriamycin-treated rabbits.
    Olson HM; Young DM; Prieur DJ; LeRoy AF; Reagan RL
    Am J Pathol; 1974 Dec; 77(3):439-54. PubMed ID: 4432914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of different iron chelators as protective agents against acute doxorubicin-induced cardiotoxicity.
    Voest EE; van Acker SA; van der Vijgh WJ; van Asbeck BS; Bast A
    J Mol Cell Cardiol; 1994 Sep; 26(9):1179-85. PubMed ID: 7815460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical assessment of anthracycline cardiotoxicity in laboratory animals: predictiveness and pitfalls.
    Robert J
    Cell Biol Toxicol; 2007 Jan; 23(1):27-37. PubMed ID: 17041747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endosulfan-induced cardiotoxicity and free radical metabolism in rats: the protective effect of vitamin E.
    Kalender S; Kalender Y; Ogutcu A; Uzunhisarcikli M; Durak D; Açikgoz F
    Toxicology; 2004 Oct; 202(3):227-35. PubMed ID: 15337585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of oxidative stress in transition of hypertrophy to heart failure.
    Dhalla AK; Hill MF; Singal PK
    J Am Coll Cardiol; 1996 Aug; 28(2):506-14. PubMed ID: 8800132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of HSP70 and ultrastructure of heart and liver tissues of rats treated with adriamycin: protective role of L-carnitine.
    Strauss M; Porras N
    Invest Clin; 2007 Mar; 48(1):33-43. PubMed ID: 17432542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation by selenium supplementation of lipid peroxidation induced by chronic administration of adriamycin in rats.
    Coudray C; Hida H; Boucher F; De Leiris J; Favier A
    Nutrition; 1995; 11(5 Suppl):512-6. PubMed ID: 8748211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of adriamycin cardiotoxicity by enoximone.
    Bossa R; Bissoli M; Chiericozzi M; Cozzi R; Galatulas I; Salvatore G
    Anticancer Res; 1996; 16(1):141-3. PubMed ID: 8615599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardioprotective properties of O-(beta-hydroxyethyl)-rutosides in doxorubicin-pretreated BALB/c mice.
    van Acker SA; Voest EE; Beems DB; Madhuizen HT; de Jong J; Bast A; van der Vijgh WJ
    Cancer Res; 1993 Oct; 53(19):4603-7. PubMed ID: 8402634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats.
    Fadillioglu E; Oztas E; Erdogan H; Yagmurca M; Sogut S; Ucar M; Irmak MK
    J Appl Toxicol; 2004; 24(1):47-52. PubMed ID: 14745846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relationship between glomerular nephrin expression and oxidative stress reaction in rats with adriamycin-induced nephrosis].
    Zhu Y; Lu L
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):56-60. PubMed ID: 19149925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protectors against doxorubicin-induced cardiotoxicity: flavonoids.
    Bast A; Kaiserová H; den Hartog GJ; Haenen GR; van der Vijgh WJ
    Cell Biol Toxicol; 2007 Jan; 23(1):39-47. PubMed ID: 17063376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphological changes in organs of mice induced by the combination of adriamycin and pustulan.
    Fiszer-Maliszewska L; Mordarski M; Madej JA; Kotz J
    Arch Immunol Ther Exp (Warsz); 1983; 31(3):365-72. PubMed ID: 6651486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac dysfunction induced by low and high diet antioxidant levels comparing selenium and vitamin E in rats.
    Turan B; Hotomaroglu O; Kiliç M; Demirel-Yilmaz E
    Regul Toxicol Pharmacol; 1999 Apr; 29(2 Pt 1):142-50. PubMed ID: 10341144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.